PR Newswire Clinical TrialsOriginal article
Fuse Oncology and Associated Medical Professionals of NY Launch Proof of Concept for End-to-End Radiation Oncology Workflow in Urology
PartnershipPositive
AI Analysis
Summary
Fuse Oncology and Associated Medical Professionals of NY announced a proof of concept launch of FuseRx, an end-to-end radiation oncology workflow platform with ACRO clinical pathways, at a Syracuse radiation oncology program. This represents a clinical partnership to evaluate the technology platform in urology practice.
Outcome Details
Proof of concept launch for FuseRx radiation oncology workflow platform with ACRO clinical pathways
Importance:4/10
Sentiment:
0.50
radiation oncologyurologyworkflow platformproof of conceptpartnership
Read the original article
Published by PR Newswire Clinical Trials on September 29, 2026 12:03 AM
